Trial intelligence / Profile preview

Nevirapine vs Zidovudine + Lamivudine for Peripartum HIV Transmission

NCT02181933Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Apr 1999
Primary completion
Jan 2001
Modality
Small Molecules
01

Overview

A Phase 3 trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Apr 1999; status: completed.

02

Drugs

nevirapine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT02181933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02181933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call